IPG Photonics — Third Quarter 2026 Earnings Summary

Financial Performance:

• Revenue for the three months ended September 30, 2026, was $287.5 million, a 15% increase year-over-year from $250.8 million; for the nine months ended September 30, 2026, revenue was $831.6 million, a 14% increase from $729.3 million.
• GAAP gross margin was 40.7% for the quarter (up from 39.5% in the prior year period) and 39.6% for the nine months (up from 38.7% in the prior year period).
• Adjusted gross margin was 41.0% for the quarter (up from 39.8%) and 39.9% for the nine months (up from 39.2%).
• Operating income was $20.8 million for the quarter (up from $7.9 million) and $17.6 million for the nine months (up from $9.8 million).
• Operating margin was 7.2% for the quarter (up from 3.1%) and 2.1% for the nine months (up from 1.3%).
• Net income was $20.3 million for the quarter, a 171% increase from $7.5 million; for the nine months, net income was $27.1 million, a 52% increase from $17.8 million.
• Earnings per diluted share were $0.47 for the quarter (up from $0.18) and $0.63 for the nine months (up from $0.42).
• Adjusted EBITDA was $51.5 million for the quarter, a 39% increase from $37.0 million; for the nine months, adjusted EBITDA was $135.2 million, a 34% increase from $101.2 million.
• Adjusted earnings per diluted share were $0.61 for the quarter (up from $0.35) and $1.49 for the nine months (up from $0.96).
• Cash flow from operations was $46 million in the third quarter; for the nine months, net cash provided by operating activities was $78.5 million.
• Capital expenditures were $17 million in the third quarter; for the nine months, purchases of and deposits on property, plant, and equipment were $54.4 million.
• Cash and cash equivalents increased to $710.7 million as of September 30, 2026, from $403.8 million as of December 31, 2025.
• Total assets were $2.47 billion as of September 30, 2026, compared to $2.42 billion as of December 31, 2025.
• Total liabilities were $317.1 million as of September 30, 2026, compared to $296.2 million as of December 31, 2025.
• Stockholders' equity was $2.15 billion as of September 30, 2026, compared to $2.13 billion as of December 31, 2025.

Guidance and Future Outlook:

• For the fourth quarter of 2026, IPG expects revenue between $265 million and $295 million.
• Adjusted gross margin for the fourth quarter is expected to be between 37.0% and 40.0%.
• Adjusted operating expenses for the fourth quarter are expected to be between $91 million and $94 million.
• Adjusted earnings per diluted share for the fourth quarter are anticipated to range from $0.30 to $0.60.
• Adjusted EBITDA for the fourth quarter is projected to be between $33 million and $50 million.
• The fourth quarter guidance assumes no contribution from the acquisition of Lumibird Medical.
• The guidance assumes exchange rates of euro 0.88, Japanese yen 157, and Chinese yuan 6.74 relative to the U.S. dollar.
• The third quarter book-to-bill ratio was approximately one.

Business Segments and Product Lines:

• Industrial Solutions revenue was $239.5 million for the quarter, a 12% increase year-over-year, accounting for 83% of total revenue; for the nine months, it was $704.2 million, a 16% increase.
• Advanced Solutions revenue was $48.0 million for the quarter, a 33% increase year-over-year; for the nine months, it was $127.4 million, a 5% increase.
• Industrial Solutions growth was driven by strong performance in welding and additive manufacturing applications.
• Advanced Solutions growth was driven by higher sales in semiconductor and defense applications.
• Emerging growth products accounted for 52% of total revenue in the third quarter, down from 58% in the prior quarter.
• The company anticipates the acquisition of Lumibird Medical, expected to close in the fourth quarter, will strengthen its reach, accelerate growth in medical markets, and increase revenue in Advanced Solutions.

Market and Competitive Landscape:

• Sales increased 14% in Asia and 33% in North America year-over-year, while sales decreased 1% in Europe.
• Changes in foreign exchange rates increased revenue by approximately 1% in the third quarter.
• The company noted improved industrial demand and continued execution of strategic growth initiatives.

Risks and Challenges:

• Actual results may differ from guidance due to trade policy changes, trade restrictions, product demand fluctuations, order cancellations, competition, tariffs, retaliatory tariffs, currency fluctuations, and general economic conditions.
• Uncertainty related to the trade environment and tariff policies increases risks to the outlook.
• Risks include potential downturns in served industries, inability to manage international risks, changes in trade controls, difficulty penetrating new applications, declining average selling prices, high fixed costs from vertical integration, manufacturing capacity appropriateness, inventory write-downs, asset impairment charges, intellectual property claims, supply interruptions, and government regulations.

Management Commentary and Tone:

• Dr. Mark Gitin, CEO, stated the company delivered its fourth consecutive quarter of double-digit year-over-year revenue growth with revenue above the midpoint of guidance.
• Management attributed performance to the strength of technology, disciplined execution, and progress in expanding presence in higher-growth markets.
• Dr. Gitin concluded that the company remains focused on driving profitable growth through innovation, technology differentiation, and operational excellence.

Other Key Points:

• Net tariff refunds of $5.0 million were recorded in the third quarter, contributing to margin expansion.
• The company spent $2.6 million on the purchase of treasury stock net of excise tax during the nine months ended September 30, 2026.
• Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock were $11.1 million for the nine months.
• The company holds 57.4 million shares issued and outstanding as of September 30, 2026.
• A conference call is scheduled for November 3, 2026, at 10:00 am ET.
• Supplemental financial information is available on the investor relations website.